These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16763468)

  • 21. Assessment of rates of acute adverse reactions to gadobenate dimeglumine: review of more than 130,000 administrations in 7.5 years.
    Fakhran S; Alhilali L; Kale H; Kanal E
    AJR Am J Roentgenol; 2015 Apr; 204(4):703-6. PubMed ID: 25794059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and adverse effects during 24 hours after contrast-enhanced MRI with gadobenate dimeglumine (MultiHance) in children.
    Schneider G; Schürholz H; Kirchin MA; Bücker A; Fries P
    Pediatr Radiol; 2013 Jan; 43(2):202-11. PubMed ID: 23179483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and safety of gadobenate dimeglumine (multihance) in subjects with impaired liver function.
    Davies BE; Kirchin MA; Bensel K; Lorusso V; Davies A; Parker JR; Lafrance ND
    Invest Radiol; 2002 May; 37(5):299-308. PubMed ID: 11979156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a novel time-efficient protocol for gadobenate dimeglumine (Gd-BOPTA)-enhanced liver magnetic resonance imaging.
    Schneider G; Altmeyer K; Kirchin MA; Seidel R; Grazioli L; Morana G; Saini S
    Invest Radiol; 2007 Feb; 42(2):105-15. PubMed ID: 17220728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Focal liver lesions: whether a standard dose (0.05 mmol/kg) gadobenate dimeglumine can provide the same diagnostic data as the 0.1 mmol/kg dose.
    Nural MS; Gokce E; Danaci M; Bayrak IK; Diren HB
    Eur J Radiol; 2008 Apr; 66(1):65-74. PubMed ID: 17555901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paediatric post-marketing pharmacovigilance: comparison of the adverse event profile of vigabatrin prescribed to children and adults.
    Aurich-Barrera B; Wilton L; Brown D; Shakir S
    Pharmacoepidemiol Drug Saf; 2011 Jun; 20(6):608-18. PubMed ID: 21351182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Visualization of the biliary tract using gadobenate dimeglumine: preliminary findings.
    Ergen FB; Akata D; Sarikaya B; Kerimoglu U; Hayran M; Akhan O; Hussain HK
    J Comput Assist Tomogr; 2008; 32(1):54-60. PubMed ID: 18303288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diffusion-perfusion in intra-axial brain tumors with high relaxivity contrast agents.
    Cotton F
    Neuroradiology; 2006 Apr; 48 Suppl 1():34-40. PubMed ID: 16699850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inter- and intra-individual comparative study of two gadolinium-based agents: A pilot study.
    Shin KS; AlObaidy M; Ramalho M; Jeon YH; Burke LM; Altun E; Stallings CG; Semelka RC
    Abdom Imaging; 2015 Apr; 40(4):865-74. PubMed ID: 25223524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical utility and safety of MultiHance in magnetic resonance imaging of liver cancer: results of multicenter studies in Europe and the USA.
    Hamm B; Kirchin M; Pirovano G; Spinazzi A
    J Comput Assist Tomogr; 1999 Nov; 23 Suppl 1():S53-60. PubMed ID: 10608398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of Gadobutrol: Results From 42 Clinical Phase II to IV Studies and Postmarketing Surveillance After 29 Million Applications.
    Endrikat J; Vogtlaender K; Dohanish S; Balzer T; Breuer J
    Invest Radiol; 2016 Sep; 51(9):537-43. PubMed ID: 26964075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of MR contrast media.
    Olukotun AY
    Radiology; 1994 May; 191(2):584-5. PubMed ID: 8153348
    [No Abstract]   [Full Text] [Related]  

  • 33. Anaphylactic reaction and cardiac arrest due to gadobenate dimeglumine.
    Virtos M; Ruiz S; Mokrane FZ; Rousseau H; Georges B; Fourcade O; Conil JM
    Anaesth Crit Care Pain Med; 2015 Aug; 34(4):247-8. PubMed ID: 26004876
    [No Abstract]   [Full Text] [Related]  

  • 34. A case of gadobenate dimeglumine-induced anaphylactic shock: a case report.
    Huang J; Liu Z; Jiang C; Xu L; Zheng W
    Ann Palliat Med; 2021 Jun; 10(6):7126-7131. PubMed ID: 34154335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose gadobenate dimeglumine versus standard-dose gadopentate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging.
    Balci NC; Inan N; Anik Y; Erturk MS; Ural D; Demirci A
    Acad Radiol; 2006 Jul; 13(7):833-9. PubMed ID: 16777557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
    Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
    Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical implication of small (<20 mm) enhancing hepatic nodules observed only during three-dimensional gadobenate dimeglumine-enhanced hepatic arterial-phase MRI of the hepatitis B virus-induced mild cirrhosis.
    Kim YK; Lee YH; Kwak HS; Kim CS; Han YM
    Clin Imaging; 2008; 32(6):453-9. PubMed ID: 19006774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gadobutrol for contrast-enhanced magnetic resonance imaging in elderly patients: review of the safety profile from clinical trial, post-marketing surveillance, and pharmacovigilance data.
    Endrikat J; Schwenke C; Prince MR
    Clin Radiol; 2015 Jul; 70(7):743-51. PubMed ID: 25933719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Observational study on the safety profile of gadoterate meglumine in 35,499 patients: The SECURE study.
    Soyer P; Dohan A; Patkar D; Gottschalk A
    J Magn Reson Imaging; 2017 Apr; 45(4):988-997. PubMed ID: 27726239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Initial experience on utility of gadobenate dimeglumine (Gd-BOPTA) enhanced T1-weighted MR cholangiography in diagnosis of acute cholecystitis.
    Akpinar E; Turkbey B; Karcaaltincaba M; Balli O; Akkapulu N; Balas S; Tirnaksiz B; Akata D; Akhan O
    J Magn Reson Imaging; 2009 Sep; 30(3):578-85. PubMed ID: 19711404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.